Mapping large numbers of results may take a few moments.
Search Results
Showing 101 - 150 of 328 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham |
| |
Company DuraVax Inc. | Activity: Research and Development | Company Description DuraVax is developing thermo-stable liquid formulations for RNA pharmaceuticals. | Location Wilmington |
| |
Company Eclipse Life Sciences Inc. | Activity: Research and Development | Company Description Eclipse Life Sciences is developing therapeutic compounds to treat front-of-the-eye diseases, such as uveitis and dry eye, as well as back-of-the-eye diseases, such as wet or dry macular degeneration or diabetic retinopathy. | Location Research Triangle Park |
| |
Company Eisai Inc. | Activity: Sales and Operations | Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. | Location Raleigh |
| |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Eli Lilly and Company (Durham) | Activity: Production and Manufacturing | Company Description Lilly specializes in drug product formulation, filling and inspection of syringes and building and packaging of auto-injectors at its RTP site | Location Durham |
| |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham |
| |
Company ENCO Pharmaceutical Development Inc. | Activity: Contract Research and Testing | Company Description ENCO Pharmaceutical Development (EPDI) provides analytical services, comprehensive stability storage and related testing, as well as a product and formulation development services. | Location Cary |
| |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville |
| |
Company Epigenos Biosciences Inc. | Activity: Research and Development | Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. | Location Morrisville |
| |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park |
| |
Company Exela Pharma Sciences LLC | Activity: Production and Manufacturing | Company Description Exela Pharma Sciences develops, manufactures and markets sterile injectable pharmaceuticals and provides contract manufacturing services. The Lenoir site is a cGMP-compliant sterile manufacturing facility. | Location Lenoir |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex |
| |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |
| |
Company FHI 360 | Activity: Contract Research and Testing | Company Description FHI 360 is a nonprofit human development organization working to improve the health and well-being of people in the U.S. and around the world. The laboratory in Durham offers medical device and pharmaceutical testing services. | Location Durham |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company FUJIFILM Diosynth Biotechnologies USA Inc. (Morrisville) | Activity: Production and Manufacturing | Company Description FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization for biologics, vaccines, cell and gene therapies, and oncolytic viruses. Services include cell line development, process and analytical development, clinical and commercial manufacturing and bioprocess research and development. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |
| |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham |
| |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company GENIE Therapeutics | Activity: Research and Development | Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. | Location Winston-Salem |
| |
Company Glenmark Pharmaceuticals Inc., USA | Activity: Production and Manufacturing | Company Description Glenmark Pharmaceuticals discovers small-molecule drugs and biologics in the areas of oncology, respiratory disease and dermatology, and manufactures and distributes APIs and generics. The Monroe site manufactures oral solids, injectables and topicals. | Location Monroe |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company Grifols (Clayton) | Activity: Production and Manufacturing | Company Description Grifols' manufacturing campus in Clayton produces plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions. | Location Clayton |
| |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company GSK (Zebulon) | Activity: Production and Manufacturing | Company Description GlaxoSmithKline manufactures solid-dose products, including tablets and capsules, at its Zebulon facility. The plant also does granulation, drying and packaging, and contract manufacturing of antibiotics for other companies. | Location Zebulon |
| |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh |
| |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Huvepharma Inc. | Activity: Production and Manufacturing | Company Description Huvepharma manufactures Coccidiosis vaccines for in ovo and post-hatch vaccination of poultry. | Location Maxton |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |